Pacific Smiles Group Limited

CHIA:PSQ Stock Report

Market Cap: AU$283.7m

Pacific Smiles Group Valuation

Is PSQ undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of PSQ when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Discounted Cash Flow
Simply Wall St
AU$6.61
Fair Value
73.2% undervalued intrinsic discount
2
Number of Analysts

Below Fair Value: PSQ (A$1.77) is trading below our estimate of fair value (A$6.61)

Significantly Below Fair Value: PSQ is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for PSQ?

Key metric: As PSQ is barely profitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for PSQ. This is calculated by dividing PSQ's market cap by their current revenue.
What is PSQ's PS Ratio?
PS Ratio1.5x
SalesAU$188.86m
Market CapAU$283.65m

Price to Sales Ratio vs Peers

How does PSQ's PS Ratio compare to its peers?

The above table shows the PS ratio for PSQ vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average1x
MVF Monash IVF Group
1.1x3.37%AU$290.3m
REG Regis Healthcare
2.2x8.21%AU$2.4b
RHC Ramsay Health Care
0.5x4.66%AU$8.1b
PGC Paragon Care
0.2x7.03%AU$670.4m
PSQ Pacific Smiles Group
1.5x6.87%AU$283.7m

Price-To-Sales vs Peers: PSQ is expensive based on its Price-To-Sales Ratio (1.5x) compared to the peer average (0.9x).

Price to Sales Ratio vs Industry

How does PSQ's PS Ratio compare vs other companies in the AU Healthcare Industry?

4 CompaniesPrice / SalesEstimated GrowthMarket Cap
PGC Paragon Care
0.2x7.03%US$429.94m
FCG Freedom Care Group Holdings
0.1xn/aUS$2.51m
HHI Health House International
0.05xn/aUS$590.30k
TTB Total Brain
0.03xn/aUS$179.68k
No more companies available in this PS range
PSQ 1.5xIndustry Avg. 1.5xNo. of Companies4PS00.81.62.43.24+
4 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: PSQ is good value based on its Price-To-Sales Ratio (1.5x) compared to the Oceanic Healthcare industry average (1.5x).

Price to Sales Ratio vs Fair Ratio

What is PSQ's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

PSQ PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio1.5x
Fair PS Ratio1.1x

Price-To-Sales vs Fair Ratio: PSQ is expensive based on its Price-To-Sales Ratio (1.5x) compared to the estimated Fair Price-To-Sales Ratio (1.1x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst PSQ forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentAU$1.77
AU$1.85
+4.52%
5.41%AU$1.95AU$1.75n/a2
May ’26AU$1.76
AU$1.85
+5.41%
5.41%AU$1.95AU$1.75n/a2
Apr ’26AU$1.93
AU$1.83
-4.76%
4.64%AU$1.95AU$1.75n/a3
Mar ’26AU$1.97
AU$1.83
-6.94%
4.64%AU$1.95AU$1.75n/a3
Feb ’26AU$1.95
AU$1.83
-5.98%
4.64%AU$1.95AU$1.75n/a3
Jan ’26n/a
AU$1.83
0%
4.64%AU$1.95AU$1.75n/a3
Dec ’25AU$1.95
AU$1.90
-2.56%
9.37%AU$2.15AU$1.75n/a3
Nov ’25AU$1.88
AU$1.90
+1.33%
9.37%AU$2.15AU$1.75n/a3
Oct ’25AU$1.81
AU$1.76
-2.90%
16.56%AU$2.15AU$1.33n/a4
Sep ’25AU$1.78
AU$1.76
-0.99%
16.56%AU$2.15AU$1.33n/a4
Aug ’25AU$1.89
AU$1.63
-13.40%
16.46%AU$1.90AU$1.33n/a4
Jul ’25AU$1.89
AU$1.51
-20.03%
15.15%AU$1.90AU$1.33n/a4
Jun ’25AU$1.90
AU$1.51
-20.66%
15.15%AU$1.90AU$1.33n/a4
May ’25AU$1.87
AU$1.51
-19.39%
15.15%AU$1.90AU$1.33AU$1.764
Apr ’25AU$1.59
AU$1.51
-4.89%
15.15%AU$1.90AU$1.33AU$1.934
Mar ’25AU$1.44
AU$1.57
+8.80%
15.04%AU$1.90AU$1.40AU$1.973
Feb ’25AU$1.45
AU$1.36
-6.21%
27.69%AU$1.80AU$0.88AU$1.953
Jan ’25AU$1.46
AU$1.24
-14.49%
32.07%AU$1.80AU$0.88n/a3
Dec ’24AU$1.03
AU$1.30
+26.51%
27.65%AU$1.80AU$0.88AU$1.954
Nov ’24AU$1.21
AU$1.68
+39.63%
14.85%AU$2.10AU$1.48AU$1.884
Oct ’24n/a
AU$1.68
0%
14.85%AU$2.10AU$1.48AU$1.814
Sep ’24AU$1.45
AU$1.68
+16.03%
14.85%AU$2.10AU$1.48AU$1.784
Aug ’24AU$1.49
AU$1.63
+9.52%
13.11%AU$2.00AU$1.48AU$1.894
Jul ’24AU$1.36
AU$1.56
+14.94%
17.57%AU$2.00AU$1.25AU$1.894
Jun ’24AU$1.35
AU$1.56
+15.80%
17.57%AU$2.00AU$1.25AU$1.904
May ’24AU$1.32
AU$1.58
+20.41%
19.69%AU$2.00AU$1.25AU$1.873
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
AU$1.87
Fair Value
5.1% undervalued intrinsic discount
2
Number of Analysts

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/20 23:22
End of Day Share Price 2025/05/20 00:00
Earnings2024/12/31
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Pacific Smiles Group Limited is covered by 5 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Nicholas CaleyEL&C Baillieu
Russell WrightMaqro Capital
James BalesMorgan Stanley